Found: 6
Select item for more details and to access through your institution.
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.
- Published in:
- Diabetologia, 2019, v. 62, n. 4, p. 665, doi. 10.1007/s00125-018-4810-0
- By:
- Publication type:
- Article
A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 60, doi. 10.1111/dom.13034
- By:
- Publication type:
- Article
Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 7, p. 2953, doi. 10.1210/jc.2019-00008
- By:
- Publication type:
- Article
Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Glucagon-Like Peptide-2 Analogue ZP1849 Augments Colonic Anastomotic Wound Healing.
- Published in:
- Gastroenterology Research & Practice, 2020, p. 1, doi. 10.1155/2020/8460508
- By:
- Publication type:
- Article
No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes.
- Published in:
- 2020
- By:
- Publication type:
- journal article